Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Integra LifeSciences Holdings Corporation (IART) had Debt to Capital Ratio of 0.62 for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$434.93M |
|
$-1.70M |
|
$214.06M |
|
$220.87M |
|
$411.88M |
|
$23.04M |
|
$-18.73M |
|
$4.31M |
|
$4.31M |
|
$-1.70M |
|
$-1.70M |
|
$-1.70M |
|
$-1.70M |
|
$23.04M |
|
$62.48M |
|
76.67M |
|
76.67M |
|
$-0.03 |
|
$-0.03 |
|
| Balance Sheet Financials | |
$1.16B |
|
$444.33M |
|
$2.44B |
|
$3.60B |
|
$455.98M |
|
$1.73B |
|
$2.10B |
|
$2.56B |
|
$1.04B |
|
$-706.36M |
|
$1.04B |
|
77.89M |
|
| Cash Flow Statement Financials | |
$50.38M |
|
$-108.06M |
|
$28.34M |
|
$246.38M |
|
$235.05M |
|
$-11.33M |
|
$18.58M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.54 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
0.62 |
1.78 |
|
50.78% |
|
5.30% |
|
5.30% |
|
-- |
|
0.99% |
|
-0.39% |
|
$-31.05M |
|
-- |
|
-- |
|
-- |
|
0.12 |
|
0.43 |
|
1.56 |
|
57.70 |
|
-0.16% |
|
0.24% |
|
-0.05% |
|
-0.06% |
|
$13.40 |
|
$-0.41 |
|
$0.66 |
|